PDF
(Download)
|
- Ashwagandha (Withania somnifera)
- Cognition
- Psychomotor Performance
|
Date:
04-15-2014
|
HC#
031451-494
|
Re:
Ashwagandha Improves Cognitive and Psychomotor Performance in Healthy Adult Males
Pingali
U, Pilli R, Fatima N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in
healthy human participants. Pharmacognosy
Res. 2014;6(1):12-18.
Ashwagandha
(Withania somnifera) is used in Ayurvedic medicine to enhance memory and
overall brain function. Many in vitro and in vivo studies demonstrate the
potential benefits of ashwagandha; however, human studies are limited. The
purpose of this randomized, double-blind, placebo-controlled, crossover study
was to evaluate the cognitive and psychomotor effects of a standardized aqueous
ashwagandha extract in healthy young male subjects.
Healthy men (n = 20,
aged 20-35 years) participated in this study conducted at Nizam's Institute of Medical Sciences; Punjagutta, Hyderabad, India. The authors confirmed that the subjects
were healthy by conducting a detailed medical history; physical examination; evaluation
of hematological, hepatic, and renal parameters; electrocardiogram (ECG); and chest X-ray. Subjects were excluded for any evidence of physical illness, drug
abuse, or aberrant laboratory findings during screening. All the subjects were
required to abstain from nicotine, caffeine, and alcohol for at least 24 hours
prior to and during the test day. Subjects were randomly assigned to receive
either placebo or 1000 mg/day of an aqueous ashwagandha root and leaf extract (Sensoril®;
Natreon Inc.; New Brunswick, New Jersey) for 14 days. As determined by high-performance thin layer chromatography analyses of the extract and
standard references, each capsule contained "not less than 10% withanolide glycosides, not more than 0.5% of withaferin-A, and not less than 32% of oligosaccharides." The
identical placebo capsules contained microcrystalline cellulose, lactose, and
magnesium stearate.
There was a 14-day
washout period before the subjects were crossed over to the other treatment for
14 days. The following psychomotor performance tests were conducted at baseline
and at the end of each crossover period: finger tapping test (evaluates motor
system performance), simple reaction test (assesses attention and sensory-motor
performance), choice discrimination test (assesses attention and sensory-motor
performance and response speed), digit symbol substitution test (assesses
attention, response speed, central integration, and visuo-motor coordination),
digit vigilance task (assesses alertness and vigilance while placing minimal
demands on the selectivity and capacity components of attention), and card
sorting test (assesses sensory, motor, central integrative, and executive
functions).
Compared
with placebo and baseline, ashwagandha significantly improved the reaction time
for the following tests: digit symbol substitution (P < 0.05 and P <
0.001, respectively), simple reaction (P < 0.01 for both), choice
discrimination (P < 0.05 for both), digit vigilance (P < 0.01 for both),
and card sorting (P < 0.05 for both). There was no significant effect on motor
system performance according to the finger tapping test. The mean percent
reduction in reaction time between groups at study end was statistically
significant for digit symbol substitution (P < 0.05), digit vigilance (P
< 0.01), and simple reaction (P < 0.05).
In summary, 1000
mg/day of standardized ashwagandha extract improved cognitive and psychomotor
performance in healthy young adult males when taken for 14 days. However, the
data cannot be extrapolated to patients with medical conditions, elderly
healthy men, or healthy women of any age. Another limitation of the study is
the small population size. The authors conclude that "multicentric long-term clinical studies in patients are required to
confirm its therapeutic efficacy in disease states associated with impaired
cognition and psychomotor function."
—Heather S. Oliff, PhD
|